Clinical research on trimebutine maleate,oryzanol and anisodamine combined application in treatment of the elderly patients with irritable bowel syndrome

VernacularTitle:曲美布汀、谷维素、山茛菪碱联合治疗老年人肠易激综合征疗效观察
Author: Wei ZHANG ; Jinping LI ; Bin DU
Publication Type:Journal Article
Keywords: Irritable bowel syndrome; Aged
From: Chinese Journal of Primary Medicine and Pharmacy 2011;18(23):3196-3197
CountryChina
Language:Chinese
Abstract: Objective To explore more effective treatments for irritable bowel syndrome(IBS)in old people.Methods 80 patients with irritable bowel syndrome were selected.adverse drug reaction during treatment,and therapy effect of a symptom score after treatment observation group and control group were compared.Results Total improvement rate of symptoms from observation group was 91.7％,and total improvement rate of symptoms in control group was 65.6％.Difference of proportions of significant improvement and improvement was significant,according to the situation that was controlled between observation group and control group.The difference of symptom score after treatment was significant,according to the situation that was controlled between observation group and control group.Conclusion Trimebutine maleate,oryzanol and anisodamine combined application could remarkably improve irritable bowel syndrome treatment effect,and was more safe.